Bafutto Mauro, Luquetti Alejandro Ostermayer, Gabriel Neto Salustiano, Penhavel Felix Andre Sanches, Oliveira Enio Chaves
Gastroenterology Division, Internal Medicine Department, School of Medicine, Universidade Federal de Goias, Goiania, Brazil.
Nucleo de Estudo da Doenca de Chagas, Hospital das Clinicas, Universidade Federal de Goias, Brazil.
Gastroenterology Res. 2017 Aug;10(4):213-217. doi: 10.14740/gr872w. Epub 2017 Aug 31.
Constipation is the main symptom of acquired chagasic megacolon. However, a number of patients with Chagas disease without colon involvement also have the same complain. This study evaluated the role of small bowel in constipated patients with Chagas disease with and without megacolon.
Orocecal transit time (OCTT) and oral glucose tolerance test (OGTT) in constipated non-chagasic and chagasic patients with and without megacolon were performed. One hundred fifteen patients were included in this study and were divided into two groups based on the presence or absence of constipation, which is defined as at least 7 days without bowel movements for more than 1 year. These two groups were further divided into three subgroups based on the serology test results for and the presence and absence of megacolon on barium enema. All patients were subjected to OCTT and OGTT.
Among 70 constipated patients, 64.3% had OCTT longer than 120 min, higher than the non-constipated patients (31.1%, P < 0.000). The proportion of patients within the three subgroups in the non-constipated group was not different from each other (P = 0.345). Among the constipated subgroup, 94.44% of the chagasic megacolon subgroup had OCTT longer than 120 min, higher than the other two subgroups (P = 0.005). Chagas patients with constipation, without or without megacolon, showed higher blood glucose levels at 30, 60, and 90 min after oral ingestion of 70 g glucose than normal subjects with or without constipation.
Constipated, either non-chagasic or chagasic, patients have a prolonged OCTT. This result suggests that slow small bowel transit may be a significant factor for constipation.
便秘是获得性恰加斯病巨结肠的主要症状。然而,许多未累及结肠的恰加斯病患者也有同样的主诉。本研究评估了小肠在有和无巨结肠的恰加斯病便秘患者中的作用。
对有和无巨结肠的便秘非恰加斯病患者及恰加斯病患者进行了口盲肠转运时间(OCTT)和口服葡萄糖耐量试验(OGTT)。本研究纳入了115例患者,根据是否存在便秘分为两组,便秘定义为至少7天无排便且持续1年以上。这两组又根据血清学检测结果以及钡灌肠时是否存在巨结肠进一步分为三个亚组。所有患者均接受OCTT和OGTT检查。
在70例便秘患者中,64.3%的患者OCTT超过120分钟,高于非便秘患者(31.1%,P<0.000)。非便秘组三个亚组患者的比例彼此无差异(P = 0.345)。在便秘亚组中,94.44%的恰加斯病巨结肠亚组患者OCTT超过120分钟,高于其他两个亚组(P = 0.005)。有便秘的恰加斯病患者,无论有无巨结肠,口服70克葡萄糖后30、60和90分钟时的血糖水平均高于有或无便秘的正常受试者。
无论是非恰加斯病还是恰加斯病,便秘患者的OCTT均延长。这一结果表明小肠转运缓慢可能是便秘的一个重要因素。